TSXV - Delayed Quote • CAD
Kane Biotech Inc. (KNE.V)
At close: April 24 at 3:55 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Marc Edwards | President, CEO & Director | 268.5k | -- | -- |
| Mr. Ray Dupuis | Chief Financial Officer | 161.69k | -- | -- |
| Mr. Kevin Cole | President & CEO of STEM Animal Health Inc | 432.52k | -- | -- |
| Mr. Dena Mehraban | General Manager of STEM Animal Health Inc | 256.15k | -- | -- |
| Dr. Robert B. Huizinga CNeph(C), M.Sc., MSc(Epi), Ph.D., R.N., RN NNC | Executive Chairman & Member of Scientific Advisory Board | -- | -- | 1966 |
| Dr. Gregory S. Schultz Ph.D. | Chief Scientific Officer & Member of Scientific Advisory Board | -- | -- | 1950 |
| Lorne Gorber | Investor Relations | -- | -- | -- |
| Ms. Lori Christofalos | Vice President of Quality & Compliance | -- | -- | -- |
| Ms. Wendy Nachtigall | Director of Marketing | -- | -- | -- |
| Nicole Sendey | Investor Relations Adviser | -- | -- | -- |
Kane Biotech Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Corporate Governance
Kane Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Mar 13, 2017Dividend Date
Upcoming Events
May 23, 2024 - May 27, 2024
Kane Biotech Inc. Earnings Call
Related Tickers
SIGY Sigyn Therapeutics, Inc.
5.75
0.00%
MBIO.CN MindBio Therapeutics Corp.
0.0550
-8.33%
COV.V Covalon Technologies Ltd.
0.9700
-11.82%
BRAX.CN Braxia Scientific Corp.
0.0050
0.00%
HEM.V Hemostemix Inc.
0.0450
-10.00%
THTX Theratechnologies Inc.
1.3600
+1.49%
BRTX BioRestorative Therapies, Inc.
1.2700
-5.93%
XENE Xenon Pharmaceuticals Inc.
39.50
-3.87%
TH.TO Theratechnologies Inc.
1.8500
-2.12%
ALVR AlloVir, Inc.
0.7800
-1.38%